A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain

The dopamine transporter (DAT), located presynaptically on dopamine neurons, provides a marker for certain neurological diseases. In particular, the DAT is depleted in Parkinson's disease, and the extent of depletion correlates with the loss of dopamine. Herein we describe the design, synthesis, and biological evaluation of technepine, the first Tc-99m-labeled SPECT imaging agent which targets the dopamine transporter in striatum. We have demonstrated that the DAT can accommodate a chelating unit attached to the 8-amine function of a tropane skeleton. Further, we have demonstrated for the first time that a molecule can be designed to carry the radionuclide Tc-99m across the blood-brain barrier in sufficient quantity to obtain in. vivo images of the striatum in monkeys. This advance will undoubtedly lead to the design of new receptor and transporter-mediated Tc-99m agents which can label specific transporter and receptor targets in the central nervous system.